Strategy Page looks at the rising rate of reported Post-Traumatic Stress Disorder (PTSD) in the forces engaged in Afghanistan and Iraq:
As expected the U.S. Army is beginning to see more widespread effects from PTSD (post-traumatic stress disorder). There are two main indicators. The suicide rate, which has gone from 9 per 100,000 troops in 2001, to 23 last year, gets most of the media attention. The less noticed indicator, which impacts a lot more people, is the use of anti-stress medications. These have gone up 76 percent since 2001. About 17 percent of all troops now take these drugs, including six percent of those in combat zones. In 2001, the troops used these drugs to about the same degree as the civilian population (ten percent.) The impact of these drugs, especially in combination, can be unpredictable. The army is still waiting to see how this increased use of anti-stress medications will play out. This is all unknown territory.
[. . .]
Nearly a century of energetic effort to diagnose and treat PTSD (including much recent attention to civilian victims, via accidents or criminal assault), had made it clear that most troops eventually got PTSD if they were in combat long enough. During World War II, it was found that, on average, 200 days of combat would bring on a case of PTSD for American troops. After World War II, methods were found to delay the onset of PTSD (more breaks from combat, better living conditions in the combat zone, prompt treatment when PTSD was detected). That’s why combat troops in Iraq and Afghanistan often sleep in air conditioned quarters, have Internet access, lots of amenities, and a two week vacation (anywhere) in the middle of their combat tour. This has extended their useful time in combat, before PTSD sets in. No one is yet sure what the new combat days average is, and new screening methods are an attempt to find out. But more troops appear to be hitting, or approaching, the limits.
